Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 326,028 | 189,680 | 134,758 | 69,418 | 163,620 |
| Marketable Securities | 305,930 | 507,749 | 338,762 | 271,924 | 365,416 |
| Receivables | 50,282 | 37,874 | 27,789 | 18,430 | 7,140 |
| Inventories | 9,682 | 6,341 | 4,070 | 5,248 | 4,175 |
| TOTAL | $717,616 | $760,250 | $526,106 | $373,477 | $547,897 |
| Non-Current Assets | |||||
| PPE Net | 9,161 | 3,180 | 3,309 | 2,662 | 3,081 |
| Intangibles | 1,108 | 2,585 | 4,062 | 5,538 | 7,015 |
| Other Non-Current Assets | 54,731 | 17,168 | 6,725 | 2,829 | 3,160 |
| TOTAL | $65,000 | $22,933 | $14,096 | $11,029 | $13,256 |
| Total Assets | $782,616 | $783,183 | $540,202 | $384,506 | $561,153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,493 | 7,222 | 3,167 | 8,786 | 3,912 |
| Accrued Expenses | 97,474 | 67,604 | 56,398 | 40,244 | 36,029 |
| TOTAL | $105,967 | $74,826 | $59,565 | $49,030 | $42,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 157 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,644 |
| Other Non-Current Liabilities | 49,640 | 9,222 | 1,558 | 191 | 0 |
| TOTAL | $49,640 | $9,222 | $1,558 | $191 | $157 |
| Total Liabilities | $155,607 | $84,048 | $61,123 | $49,221 | $42,742 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,048 | 155,340 | 143,882 | 124,702 | 121,408 |
| Common Shares | 16 | 15 | 14 | 12 | 12 |
| Retained earnings | -1,985,706 | -1,704,122 | -1,468,863 | -1,223,671 | -933,979 |
| Other shareholders' equity | 36 | 297 | -372 | -399 | 106 |
| TOTAL | $627,009 | $699,135 | $479,079 | $335,285 | $518,411 |
| Total Liabilities And Equity | $782,616 | $783,183 | $540,202 | $384,506 | $561,153 |